RIVASTIGMINE 1.5 MG CAPSULE

RIVASTIGMINE TARTRATE
$0.1631per EA

Strength

1.5 mg/1

NDC

33342008909

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

RIVASTIGMINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203148

On Market Since

9/2/2014

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price History

1W

0.0%

1M

+9.0%

3M

+11.8%

6M

-12.5%

1Y

-12.4%

3Y

-26.0%

5Y

-47.8%

All

-88.9%